Orange Book product · Generic (ANDA)
TORSEMIDE
TORSEMIDE
At a glance
May 01, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 01, 2026
2 mo ago
Today
Pharmaceutical detail
Active ingredient
TORSEMIDE
Strength
5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 217239
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TORSEMIDE
- 2021SOAANZBrand (NDA)
NDA 213218 · SARFE PHARMS
- 1993DEMADEXBrand (NDA)
NDA 020137 · ROCHE
- 1993DEMADEXBrand (NDA)
NDA 020136 · PHARMOBEDIENT
- 2011TORSEMIDEGeneric (ANDA)
ANDA 090613 · STRIDES PHARMA INTL
- 2010TORSEMIDEGeneric (ANDA)
ANDA 090656 · AM REGENT
- 2009TORSEMIDEGeneric (ANDA)
ANDA 079234 · HETERO LABS LTD III
- 2008TORSEMIDEGeneric (ANDA)
ANDA 078007 · HIKMA
- 2008TORSEMIDEGeneric (ANDA)
ANDA 078478 · SUN PHARM INDS
- 2007TORSEMIDEGeneric (ANDA)
ANDA 078249 · AUROBINDO PHARMA
- 2005TORSEMIDEGeneric (ANDA)
ANDA 076894 · COREPHARMA
- 2005TORSEMIDEGeneric (ANDA)
ANDA 076943 · HIKMA
- 2003TORSEMIDEGeneric (ANDA)
ANDA 076346 · PLIVA PHARM IND
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
